Category: Stem Cells

U.S. asks for stem cell ruling stay

August 31, 2010 by MassDevice staff

The U.S. Justice Dept. asked a federal judge to stay ruling barring federal funding of research that uses embryonic stem cells, citing the "magnitude of harms occurring each day that the preliminary injunction remains in effect," according to news reports.

Neuralstem aims to treat paralysis in spinal injury stem cell trial

August 27, 2010 by MassDevice staff

Neuralstem Inc. (AMEX:CUR) asked the Food & Drug Administration for permission to begin a clinical trial of a chronic spinal injury treatment using stem cells.

The Rockville, Md.-based company's Phase I clinical safety trial would employ its adult stem cell technology with cells derived from spinal cords to treat 16 patients with American Spinal Injury Assn. Grade A level of impairment, or complete paralysis, one to two years after the injury that caused their condition.

ThermoGenesis to mount reverse stock split

August 26, 2010 by MassDevice staff

ThermoGenesis Corp. (NSDQ:KOOL) will reverse-split its stock tomorrow.

The board of the Rancho Cordova, Calif.-based company approved the move in an attempt to boost its share price. ThermoGenesis faces being de-listed from the NASDAQ stock exchange unless it meets the market's minimum $1-per-share requirement.

Obama appeals stem cell ruling

August 25, 2010 by MassDevice staff

President Barack Obama's administration will appeal a controversial ruling issued earlier this week that put a temporary stop to federal funding of research involving stem cells derived from human embryos, according to news reports.

Federal judge nixes embryonic stem cell research

August 24, 2010 by MassDevice staff

A federal judge temporarily halted federal funding of research using embryonic stem cells, creating consternation among medical researchers and celebration among Christian activists opposed to the research.

UMinn researchers use bone marrow stem cells to repair skin

August 12, 2010 by MedCity News

University of Minnesota researchers have successfully repaired damaged skin tissue using stem cells gleaned from bone marrow.

In a study published today in the New England Journal of Medicine, researchers from the school’s Stem Cell Institute said the therapy can help patients who suffer from recessive dystrophic epidermolysis bullosa, a painful genetic skin disorder that causes skin to blister and scrape off at the slightest friction or trauma.